As of May 2022 Moderna has a market cap of $54.85 Billion. This makes Moderna the world's 268th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $54.85 B | -46.73% |
2021 | $102.97 B | 149.1% |
2020 | $41.33 B | 528.01% |
2019 | $6.58 B | 31.11% |
2018 | $5.02 B |
On May 15th, 2022 the market cap of Moderna was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $465.36 B | 748.35% | ๐บ๐ธ USA |
![]() Novartis NVS | $190.43 B | 247.15% | ๐จ๐ญ Switzerland |
![]() Merck MRK | $228.62 B | 316.79% | ๐บ๐ธ USA |
![]() Regulus Therapeutics RGLS | $0.03 B | -99.94% | ๐บ๐ธ USA |
![]() Dicerna Pharmaceuticals DRNA | $2.97 B | -94.57% | ๐บ๐ธ USA |
![]() Athersys ATHX | $0.14 B | -99.73% | ๐บ๐ธ USA |
![]() Alnylam Pharmaceuticals
ALNY | $15.27 B | -72.15% | ๐บ๐ธ USA |
![]() Arrowhead Pharmaceuticals
ARWR | $3.34 B | -93.90% | ๐บ๐ธ USA |